1KJ:F:F-10X GENOMICS DL -00001 (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 19.2

Change

0.00 (0.00)%

Market Cap

USD 2.54B

Volume

300.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 35.91B
2HE:F Healthequity Inc

N/A

USD 5.98B
4YC:F M3 INC.

N/A

USD 5.81B
6HL0:F R1 RCM Inc

N/A

USD 5.45B
9EH:F Evolent Health Inc

N/A

USD 3.16B
6JM:F JMDC INC.

N/A

USD 1.93B
OC9:F Omnicell Inc

N/A

USD 1.78B
19P:F Phreesia Inc

N/A

USD 1.29B
1XZ:F Ping An Healthcare and Technol..

N/A

USD 1.23B
4LL:F Teladoc Inc

N/A

USD 1.23B

ETFs Containing 1KJ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -62.88% 12% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.88% 12% F 5% F
Trailing 12 Months  
Capital Gain -59.12% 18% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.12% 15% F 9% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -16.11% 27% F 14% F
Dividend Return -16.11% 24% F 13% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.06% 59% D- 52% F
Risk Adjusted Return -64.30% 35% F 18% F
Market Capitalization 2.54B 92% A 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.